Abstract Introduction Mangiferin (2-D-glucopyranosyl-1, 3, 6, 7-tetrahydroxy-9H-xanthen-9-
one) is extracted from different part of plants such seed, peel, and kernels of mango …

The current review article is an attempt to explain the therapeutic potential of mangiferin, a
bioactive compound of the mango, against lifestyle-related disorders. Mangiferin (2-β-D …

Ginkgolide B (GB), a main constituent of Ginkgo biloba extracts, reduces hepatic lipid
accumulation and ameliorates nonalcoholic fatty liver disease (NAFLD) in obese mice, but …

Abstract Mangiferin (1, 3, 6, 7‑tetrahydroxyxanthone‑C2‑β‑D‑glucoside) is a bioactive
ingredient predominantly isolated from the mango tree, with potent antioxidant activity and …

Over the last era, small molecules sourced from different plants have gained attention for
their varied and long‐term medicinal benefits. Their advantageous therapeutic effects in …

Background Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent liver
diseases around the world, and is closely associated with obesity, diabetes, and insulin …

Although mangiferin which is a naturally occurring glucosylxanthone has exhibited
promising anticancer activities, the detailed molecular mechanism of mangiferin on cancers …

Once the balance between lipid anabolism and catabolism is broken, metabolic disorder will
occur in the organism and finally lead to metabolic diseases, such as nonalcoholic fatty liver …

Objective: Mangiferin (MGF) is a natural xanthone, with regulation effect on lipid metabolism.
However, the molecular mechanism remains unclear. We purposed after oral administration …

Mangiferin, present in Mangifera indica bark, was reported to produce hypoglycemic and
antidiabetic activity in an animal model of genetic type 2 diabetes and in streptozotocin …